PCRX Pacira BioSciences, Inc.
Price Chart
Executive Summary
Kristen Williams, an officer of Pacira BioSciences, filed a Form 144 intent to sell 10,259 shares of common stock, valued at approximately $228,468 based on a June 4, 2026 market price of $22.28. The shares were acquired through restricted stock vesting on June 3, 2026, as compensation. The sale is a routine post-vesting monetization by an officer, representing a small fraction of the company's $878M market cap, and does not signal material insider concern.
Actionable Insight
Form 144 signals intent to sell, not a completed transaction. The small dollar amount relative to market cap and routine nature (post-RSU vesting) make this a neutral event. No immediate trading signal; monitor for any follow-on Form 4 filings to confirm execution.
Key Facts
- Officer Kristen Williams filed Form 144 to sell 10,259 shares of PCRX common stock
- Proceeds estimated at ~$228,468 based on filing date price (~$22.28/share)
- Shares acquired via restricted stock vesting on June 3, 2026 (compensation)
- Sale executed through Fidelity Brokerage Services LLC
- Company market cap ~$878M; proposed sale ~0.026% of outstanding shares
- Reporting owner is an officer of Pacira BioSciences
Financial Impact
Proposed sale of ~$228K in shares, ~0.026% of market cap — immaterial
Risk Factors
- Insider could still execute the sale, but magnitude is too small to affect stock
- No material negative signal from an officer selling RSU shares for cash
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004324 |
| Document: 0001959173-26-004324-index.html | 0001959173-26-004324 |
| Document: 0001959173-26-004324.txt | 0001959173-26-004324 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 13, 2026
4d ago
|
Insider Cluster
| $22.74 $22.82 | ▲ +0.35% | ▲ +0.95% | $22.82 (+0.35%) |
|
Jun 4, 2026
12d ago
|
DEFA14A
| $22.75 $22.86 | ▲ +0.48% | ▲ +0.26% | $22.82 (+0.31%) |
|
Jun 4, 2026
12d ago
|
144
| $22.67 $22.75 | ▲ +0.35% | ▲ +2.95% | $22.82 (+0.66%) |
|
Jun 1, 2026
15d ago
|
DEFA14A
| $22.25 $22.32 | ▲ +0.31% | ▲ +1.04% | $22.82 (+2.56%) |
|
May 27, 2026
20d ago
|
DEFA14A
| $23.68 $23.22 | ▼ −1.94% | ▼ −2.18% | $22.82 (−3.63%) |
|
May 26, 2026
21d ago
|
DEFA14A
| $24.04 $23.68 | ▼ −1.50% | ▼ −2.05% | $22.82 (−5.07%) |
|
May 20, 2026
27d ago
|
DEFA14A
| $23.48 $23.35 | ▼ −0.55% | ▼ −1.00% | $22.82 (−2.81%) |
|
May 20, 2026
27d ago
|
Press Release
| $23.00 $23.48 | ▲ +2.09% | ▲ +1.89% | $22.82 (−0.78%) |
|
Apr 30, 2026
6w ago
|
8-K
| $24.44 $24.69 | ▲ +1.02% | ▲ +1.36% | $22.82 (−6.63%) |
|
Apr 17, 2026
8w ago
|
PREC14A
| $24.90 $24.64 | ▼ −1.04% | ▼ −0.39% | $22.82 (−8.35%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access